1910
ActiveAI-nativeMultimodal AI Platform for Modality Agnostic Drug Discovery™
What it does
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
Its site says now · captured 2026-08-23
1910 | AI-native biotech
Discover 1910 — a multimodal, modality-agnostic AI infrastructure for pharma. Our ITO™ platform integrates wet lab, computational, and proxy data to help companies reliably drug the undruggable.
Next to it in Healthcare and bio · AI-native multimodal drug discovery
- Synkrino BiotherapeuticsY Combinator S18
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
- VemiCo LtdSOSV SOSV IndieBio RebelBio 08
From gut microbiota to therapeutics via AI and synthetic biology
- EVQLVTechstars TS 2020
EVQLV: Accelerating the speed that healing reaches those in need
- Forcyte BiotechnologiesY Combinator W21
Discover drugs that control how much cells "squeeze" to treat disease
- Output BiosciencesY Combinator S21
The foundation for the next era of biology
- Parallel BioY Combinator S21
Using the immune system to cure disease
- Verge GenomicsY Combinator S15
We use human data and AI to develop better drugs faster.
- Diffuse BioY Combinator W23
Generative AI for protein design